Clinical Trials Directory

Trials / Completed

CompletedNCT02238639

Pulmonary Embolism as a Cause of COPD Exacerbations

Efficacy and Safety of an Active Strategy for the Diagnosis and Treatment of Acute Pulmonary Embolism (PE) in Patients With Unexplained Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): a Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
746 (actual)
Sponsor
Ministry of Health, Spain · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to demonstrate the clinical benefits of an active strategy for the diagnosis and treatment of PE compared to usual care in patients with unexplained exacerbations of COPD who require hospital admission. The secondary objective is to assess the safety of an active strategy for the diagnosis and treatment of PE compared to usual care in patients with unexplained exacerbations of COPD who require hospital admission.

Conditions

Interventions

TypeNameDescription
PROCEDUREDiagnostic and therapeutic strategy: Highly sensitive D-dimer testing and, if positive, multidetector computed tomographic pulmonary angiography (MDCT).If MDCT is positive for pulmonary embolism, patients will receive anticoagulant treatment according to updated guidelines. If MDCT is negative for pulmonary embolism, patients will receive standard management for their exacerbation.

Timeline

Start date
2014-10-01
Primary completion
2020-10-01
Completion
2020-12-01
First posted
2014-09-12
Last updated
2022-12-01
Results posted
2022-11-07

Locations

19 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT02238639. Inclusion in this directory is not an endorsement.